You are here

Home

Clinical Trials: Wounds and Injuries

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Wednesday, July 21, 2021 - 12:00
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)
Condition:   Skin Ulcer Venous Stasis Chronic
Interventions:   Biological: allo-APZ2-CVU;   Drug: Placebo
Sponsors:   RHEACELL GmbH & Co. KG;   FGK Clinical Research GmbH;   Ticeba GmbH
Not yet recruiting
Posted: Wednesday, July 7, 2021 - 12:00
Application of hUC-MSCs in Treating Acute Lung Injury: a Single Center Prospective Clinical Research
Condition:   Acute Lung Injury
Intervention:   Biological: human derived umbilical cord derived mesenchymal stem cells
Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University
Recruiting
Posted: Monday, June 14, 2021 - 12:00
A DERMO-EPIDERMAL AUTOLOGOUS SKIN SUBSTITUTE FOR FURTHER THERAPEUTIC USE
Condition:   Plastic Surgeries
Interventions:   Biological: BLOOD SAMPLES;   Biological: surgical tissue samples
Sponsor:   Assistance Publique Hopitaux De Marseille
Recruiting
Posted: Monday, May 17, 2021 - 12:00
Regeneration of Posterior Cruciate Ligament Injury Using Hypoxic Conditioned Allogenic Adipose Mesenchymal Stem Cell and Condition Medium
Conditions:   Adypose Mesenchimal Stem Cell;   Ligament Rupture;   Ligament Derived Conditined Medium
Intervention:   Biological: adypose mesenchymal conditioned medium and ligament derived conditioned medium
Sponsor:   Gadjah Mada University
Recruiting
Posted: Tuesday, March 23, 2021 - 12:00
Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI
Conditions:   Spinal Cord Injury, Acute;   Spinal Cord Injury at C4 Level With Complete Lesion;   Spinal Cord Injury at C5-C7 Level With Complete Lesion
Intervention:   Biological: Neural precursor cells derived from human embryonic stem cell line
Sponsors:   S.Biomedics Co., Ltd.;   Linical Co., Ltd.;   Yonsei University
Not yet recruiting
Posted: Monday, December 21, 2020 - 12:00
Amnion Bilayer and Stem Cell Combination Therapy on Thin Endometrium Infertile Patients
Condition:   Cell- and Tissue-Based Therapy
Interventions:   Biological: Amnion only;   Biological: Amnion - endometrium cells;   Biological: Amnion - amnion epithelial cells;   Biological: Amnion-EnSC-AESC
Sponsor:   Indonesia University
Recruiting
Posted: Tuesday, November 3, 2020 - 12:00
Clinical Study to Evaluate Efficacy and Safety of ASC(Autologous Adipose-derived Stem Cells) and Fibringlue or Fibringlue in Patients With Crohn's Fistula
Condition:   Crohn's Fistula
Interventions:   Biological: ASC(Autologous Adipose-derived Mesenchymal Stem Cells);   Drug: Fibringlue
Sponsor:   Anterogen Co., Ltd.
Recruiting
Posted: Tuesday, September 29, 2020 - 12:00
Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.
Condition:   Diabetic Foot Ulcer
Interventions:   Biological: ALLO-ASC-DFU;   Procedure: Vehicle Sheet
Sponsor:   Anterogen Co., Ltd.
Recruiting
Posted: Friday, September 4, 2020 - 12:00
Mesenchymal Stem Cell-derived Pleiotropic Factor in the Treatment of Poor Healing of Postoperative Incision
Condition:   MSCs Derived Pleiotropic Factors in Treating Poorly Healed Wounds
Intervention:   Biological: The pleiotropic factor derived from mesenchymal stem cells
Sponsors:   Chinese PLA General Hospital;   Gansu Provincial Maternity and Child-Care Hospital
Not yet recruiting
Posted: Wednesday, September 2, 2020 - 12:00
Effects of MSCs Derived Pleiotropic Factors on Wound Healing in Endonasal Surgeries
Condition:   MSCs Derived Pleiotropic Factors on Wound Healing in Endonasal Surgeries
Interventions:   Biological: MSCs Derived Pleiotropic Factors;   Other: physiological saline
Sponsor:   Chinese PLA General Hospital
Not yet recruiting

Pages